Brain MRI Characteristics of Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Their Associations with 2-Year Clinical Outcome
AJNR 39:824-829, Zhang, T.,et al, 2018
Autoimmune Post-Herpes Simplex Encephalitis of Adults and Teenagers
Neurol 85:1736-1743, 1730, Armangue, T.,et al, 2015
Hashimotos Encephalopathy: A Report of Three Cases and Relevant Literature Reviews
Int J Clin Exp Med 8:16817-16826, Zhu, Y.,et al, 2015
Whipple Limbic Encephalitis
Arch Neurol 68:1471-1473, Blanc, F.,et al, 2011
Anti-NMDA Receptor Encephalitis in Japan: Long-Term Outcome Without Tumor Removal
Neurol 70:504-511,500, Iizuka,T.,et al, 2008
Magnetic Resonance Imaging of Limbic Encephalitis
Neuroradiology 33:520-523, Kodama,T.,et al, 1991
Evolution of Brain MRI Abnormalities in Limbic Encephalitis
Neurol 40:1304-1306, Dirr,L.Y.,et al, 1990
A Case-Based Review of Cerebral Venous Infarcts with Perfusion Imaging and Comparision to Arterial Ischemic Stroke
Front Radiol 1:687045, Li, A.Y.,et al, 2021
Infliximab for the Treatment of CNS Sarcoidosis
Neurol 89:2092-2100, Gelfand, J.M.,et al, 2017
Clinicopathologic Conference, Neurosarcoidosis
NEJM 374:1966-1975, Case 15-2016, 2016
Value of MRI of the Brain in Patients with Systemic Lupus Erythematosus and Neurologic Disturbance
Neuroradiol 46:15-21, Jennings, J.E.,et al, 2014
PML-IRIS in a patient treated with Brentuximab
Neurol 79:2075-2077, Geldern, G.,et al, 2012
Hemorrhagic Manifestations of Reversible Cerebral Vasoconstriction Syndrome: Frequency, Features, and Risk Factors
Stroke 41:2505-2511, 2455, Ducros,A.,et al, 2010
Clinical Spectrum of Reversible Posterior Leukoencephalopathy Syndrome
Arch Neurol 65:205-210,175, Lee,V.H.,et al, 2008
MRI Outcomes in a Placebo-Controlled Trial of Natalizumab in Relapsing MS
Neurol 68:1390-1401, Miller,D.H.,et al, 2007
Natalizumab Plus Interferon Beta -1a for Relapsing Multiple Sclerosis
NEJM 354:911-923,965, Rudick,R.A.,et al, 2006
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 354:899-910,965, Polman,C.H.,et al, 2006
Progression of White Matter Lesions and Hemorrhages in Cerebral Amyloid Angiopathy
Neurol 67:83-87, Chen,Y.W.,et al, 2006
Management of Acute Cerebellar Stroke
Arch Neurol 62:537-544, Jensen,M.B. &St. Louis,E.K., 2005
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 348:14-23, Miller,D.H.,et al, 2003
Vasogenic Edema in Bickerstaff's Brainstem Encephalitis
Neurol 61:836-838, Weidauer,S.,et al, 2003
Magnetic Resonance Imaging of Cerebral Microbleeds
Current Opinion in Neurology 13:69-73, Roob,G.&Fazekas,F., 2000
MRI Detection of New Hemorrhages:Potential Marker of Progression in Cerebral Amyloid Angiopathy
Neurol 53:1135-1138, Greenberg,S.M.,et al, 1999
Cerebral Amyloid Angiopathy:Propsects for Clinical Diagnosis and Treatment
Neurol 52:690-694, Greenberg,S.M., 1998
A 29-Year-Old Man with Multiple Sclerosis
JAMA 280:1432-1439, Rudick,R.A., 1998
Cerebellar Hemorrhagic Infarction
Neurol 46:346-349, Chaves,C.J.,et al, 1996
Neutralizing Antibodies During Treatment of Multiple Sclerosis with Interferon Beta-1b
IFNB MS Study Group & UBC MS. MRI Analysis Group, Neurol 47:889-8946., , 1996
Magnetic Resonance Imaging of Cerebral Lesions in Pts with the Sjogren Syndrome
Ann Int Med 108:815-823, Alexander,E.L.,et al, 1988